Evidence map›Paper›PMID 41073834›Full record

Trial reportGeroScience2026

Combined creatine and HMB co-supplementation improves functional strength independent of muscle mass in physically active older adults: a randomized crossover trial.

Rafael Ramos-Hernández, Álvaro Miguel-Ortega, María Martínez-Ferrán, Diego Fernández-Lázaro, Natalia Busto, Juan Mielgo-Ayuso

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in GeroScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07343999 (A Prospective, Randomized, Multicenter Clinical Trial on the Effect of a Home-Based Multicomponent Exercise Program Combined With Nutritional Supplementation in Patients With Transthyretin Cardiac Amyloidosis), which is not on this map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07343999 nanot yet recruitingnot on this map

A Prospective, Randomized, Multicenter Clinical Trial on the Effect of a Home-Based Multicomponent Exercise Program Combined With Nutritional Supplementation in Patients With Transthyretin Cardiac Amyloidosis

TypeinterventionalSponsorUniversidad de BurgosRan2026 to 2027Enrolled102ConditionsTransthyretin Cardiac AmyloidosisArmsUsual Care, Home-Based Multicomponent Exercise Program, Fiber Supplementation (Microcrystalline Cellulose), Creatine and HMB Supplementation
3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Rafael Ramos-HernándezFaculty of Health Sciences, University of Burgos (UBU), 09001, Burgos, Spain.
Álvaro Miguel-OrtegaFaculty of Education, Alfonso X El Sabio University (UAX), 28691, Madrid, Spain.
María Martínez-FerránFaculty of Health Sciences, University of Burgos (UBU), 09001, Burgos, Spain.
Diego Fernández-LázaroResearch Group "Nutrition and Physical Activity", Spanish Nutrition Society "SEÑ", 28010, Madrid, Spain.
Natalia BustoFaculty of Health Sciences, University of Burgos (UBU), 09001, Burgos, Spain.
Juan Mielgo-AyusoFaculty of Health Sciences, University of Burgos (UBU), 09001, Burgos, Spain. jfmielgo@ubu.es.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sarcopenia is a major contributor to frailty and functional decline among older adults. Combining exercise with nutritional strategies such as creatine monohydrate (CRE) and β-hydroxy-β-methylbutyrate (HMB) supplementation may help to preserve strength and independence. To evaluate the effects of 6-week CRE + HMB supplementation combined with an integral physical conditioning (IPC) program on functional strength and body composition in physically active older adults. In a randomized, double-blind, placebo-controlled crossover trial, 30 older adults (20 men, 10 women; ≥ 60 years) completed two 6-week intervention periods (CRE + HMB or placebo) separated by a 3-week washout. The IPC program performed in both conditions consisted of four supervised weekly sessions combining strength, power, multicomponent circuits, high-intensity interval and moderate intensity continuous training), performed at 40-100% training heart rate (THR) and 20-90% one-repetition maximum (1RM) and structured as warm-up, main part and cooldown. Functional strength and body composition (bioelectrical impedance analysis) were assessed pre- and post-intervention, respectively. Significant time × group interactions were observed for fat mass, fat-free mass, total muscle mass, skeletal muscle mass, appendicular skeletal muscle mass, muscle mass index, skeletal muscle index and ALM/BMI (all p < 0.05). The CRE + HMB group showed reductions in fat mass and body fat percentage, with slight numerical increases in muscle parameters, whereas the placebo group exhibited opposite trends. However, within-group changes were not statistically significant. In contrast, CRE + HMB significantly improved multiple functional strength outcomes, including leg/back strength, arm flexion strength, upper-body endurance (dumbbell flexion, push-ups, isometric hold) and core endurance (crunches). Regression analyses suggested that these improvements were largely independent of changes in muscle mass, supporting a potential neuromuscular mechanism. Six weeks of CRE + HMB supplementation combined with IPC enhanced functional strength and endurance in active older adults, largely independent of changes in muscle mass. This combined approach represents a promising strategy for preserving functional capacity and promoting healthy ageing.

Indexed as

CreatineDietary SupplementsMuscle StrengthSarcopeniaValeratesAgedBody CompositionCross-Over StudiesDouble-Blind MethodFemaleHumansMaleMiddle AgedMuscle, Skeletalbeta-hydroxyisovaleric acidCreatineValeratesBody compositionCreatine monohydrateFunctional strengthHealthy agingMulticomponent exerciseMuscle qualityNeuromuscular adaptationsOlder adultsSarcopeniaβ-Hydroxy-β-methylbutyrate

Identifiers

PMID41073834
PMCPMC13356226

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.